MiniMed Group develops, manufactures, and markets medical devices for diabetes management, including insulin pumps and related connected care systems. Spun out from Medtronic, it is known for an integrated ecosystem that links delivery devices, continuous glucose monitoring, and software for automated insulin delivery. Its customers are people with diabetes and the clinicians who support them, with a focus on intensive insulin therapy.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 687 | — | -10 | — |
| Q2 2025 | 724 | — | -209 | — |
| Q1 2026 | 790 | 15% | -119 | — |
| Q2 2026 | 837 | 15.6% | -185 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Commvault Systems, Inc. (CVLT), Ligand Pharmaceuticals Incorporated (LGND), Remitly Global, Inc. (RELY), Nexstar Media Group, Inc. (NXST), Balchem Corporation (BCPC), Frontdoor, Inc. (FTDR)